These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16794500)

  • 1. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
    Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
    J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoreduction for intraocular retinoblastoma in Malaysia.
    Menon BS; Juraida E; Alagaratnam J; Mohammad M; Ibrahim H; George TM; Ariffin H; Ho C; Khuzaiah R; Peng LH
    J Pediatr Hematol Oncol; 2007 Jan; 29(1):2-4. PubMed ID: 17230058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative therapy in intraocular retinoblastoma: response/recurrence rate.
    Schiavetti A; Hadjistilianou T; Clerico A; Bonci E; Ragni G; Castello MA
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):3-6. PubMed ID: 15654270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country.
    Chantada GL; Fandiño AC; Raslawski EC; Manzitti J; de Dávila MT; Casak SJ; Scopinaro MJ; Schvartzman E
    Pediatr Blood Cancer; 2005 May; 44(5):455-60. PubMed ID: 15558702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
    Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
    Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.